GleamWall
中文EN

STE STERIS plc

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1757898 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.1%
TTM net income YoY20.1%
TTM EPS YoY21.7%
Revenue 3-yr CAGR8.6%
Net income 3-yr CAGR14.6%

Margins

Gross margin44.6%
Operating margin19.0%
Net margin13.4%
FCF margin15.2%
EBITDA margin27.0%

Returns

ROE11.6%
ROA7.8%
ROIC (approx.)10.0%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets32.1%
Debt / equity0.26x
Current ratio2.05x
Interest coverage20.53x

Cash quality & payout

Operating cash flow / net income1.56x
Accruals ratio-4.4%
Payout ratio30.5%
Capex / revenue5.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$1.59B$1.49B$1.59B$1.50B$1.46B$1.39B$1.48B$1.37B
Cost of revenue$877.80M$808.60M$891.20M$840.70M$814.40M$763.10M$839.40M$760.20M
Gross profit$710.80M$684.20M$697.10M$655.50M$645.90M$628.00M$641.20M$610.30M
R&D expense$31.50M$28.60M$28.80M$29.50M$28.20M$26.40M$27.60M$27.40M
SG&A expense$366.00M$369.70M$351.80M$352.30M$349.70M$353.80M$333.90M$335.50M
Operating income$294.30M$285.80M$316.80M$273.20M$265.80M$246.00M$216.10M$245.30M
Interest expense$11.20M$15.80M$15.10M$14.90M$14.90M$15.90M$17.20M$19.10M
Pretax income$288.00M$273.50M$304.50M$257.80M$253.10M$231.90M$197.30M$228.70M
Income tax$73.90M$72.50M$84.20M$63.50M$60.60M$53.90M$50.45M$55.40M
Net income$213.70M$200.10M$220.20M$192.90M$191.90M$177.40M$145.60M$173.50M
EBITDA$419.90M$409.60M$440.20M$395.20M$387.50M$365.40M$338.40M$371.20M
EPS (basic)———1.961.951.80—1.76
EPS (diluted)———1.961.941.79—1.75
Dividends declared per share0.690.630.630.630.630.570.570.57
Weighted avg. shares (diluted)97.60M97.90M—98.60M98.80M98.80M—98.90M
Balance sheet
Cash & equivalents$531.10M$482.30M$439.60M$423.70M$319.20M$279.70M$171.70M$155.20M
Receivables$1.01B$1.01B$1.09B$990.60M$947.30M$947.10M$1.04B$915.20M
Inventory$737.00M$712.10M$631.80M$673.50M$658.50M$641.20M$581.30M$649.56M
Current assets$2.48B$2.45B$2.39B$2.29B$2.11B$2.06B$2.00B$1.90B
PP&E, net$2.19B$2.17B$2.16B$2.13B$2.09B$2.05B$1.96B$1.92B
Goodwill$4.18B$4.19B$4.19B$4.23B$4.22B$4.22B$4.10B$4.04B
Intangibles$1.50B$1.56B$1.62B$1.69B$1.75B$1.82B$1.85B$1.92B
Total assets$10.71B$10.74B$10.74B$10.59B$10.41B$10.40B$10.15B$10.01B
Current liabilities$1.21B$1.28B$1.15B$922.30M$888.90M$926.60M$1.02B$891.12M
Short-term debt$243.10M$243.40M$118.90M$0$0$0$125.00M$125.00M
Long-term debt$1.65B$1.65B$1.81B$1.90B$1.90B$1.90B$1.92B$2.04B
Total debt$1.89B$1.89B$1.93B$1.90B$1.90B$1.90B$2.04B$2.16B
Total liabilities$3.44B$3.51B$3.54B$3.42B$3.39B$3.44B$3.53B$3.58B
Shareholders' equity$7.26B$7.21B$7.18B$7.15B$7.01B$6.96B$6.60B$6.42B
Net debt$1.36B$1.41B$1.49B$1.47B$1.58B$1.62B$1.87B$2.01B
Shares outstanding97.10M97.50M97.80M98.10M98.10M98.50M98.30M98.25M
Cash flow statement
Operating cash flow$289.00M$367.10M$335.40M$298.20M$287.80M$420.00M$260.80M$332.80M
Capital expenditure$76.10M$87.50M$90.20M$98.70M$86.50M$93.60M$70.90M$89.20M
Free cash flow$212.90M$279.60M$245.20M$199.50M$201.30M$326.40M$189.90M$243.60M
Investing cash flow-$76.10M-$108.50M-$217.20M-$98.50M-$88.30M-$108.50M-$69.80M-$123.90M
Financing cash flow-$163.50M-$213.50M-$97.90M-$98.00M-$159.20M-$213.10M-$178.10M-$214.40M
Depreciation & amortization$125.60M$123.80M$123.40M$122.00M$121.70M$119.40M$122.30M$125.90M
Stock-based compensation$21.70M$12.80M$12.90M$15.70M$21.20M$11.90M$9.80M$15.30M
Dividends paid$67.00M$61.40M$61.80M$61.90M$61.90M$56.20M$56.00M$56.20M
Share buybacks$100.40M$115.50M$74.30M$50.10M$100.50M$10.60M$200,000$100.50M

Free plan shows the latest 8 periods; Pro shows all 38 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.